WSJ News Exclusive | J&J Consumer-Health IPO Process to Kick Off Key Test for Moribund New-Issue Market
Kenvue plans to start meeting with prospective investors as early as Monday.
Kenvue plans to start meeting with prospective investors as early as Monday.
The companies said Dupixent showed positive results in a late-stage study of current or former smokers with the killer disease.